Who owns Mineralys Therapeutics Inc (MLYS)? Superinvestor holders

1 superinvestor of the 157 tracked here holds Mineralys Therapeutics Inc (MLYS) in their latest 13F filing, a position of $207.6M. Peter Kolchinsky gives it the most weight: 1.80% of the reported portfolio. Steve Cohen sold out of it in their latest quarter.

Hold it now
1
of 157 tracked
Combined value
$207.6M
Bought / sold
0 / 1
last quarter

Key facts

Superinvestors holding it
1 of 157
Biggest holder
Peter Kolchinsky, $207.6M
Largest weight
Peter Kolchinsky, 1.80%of their portfolio
Combined value
$207.6M
Bought last quarter
0
Sold last quarter
1

From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.

Superinvestors holding MLYS, latest filings
#InvestorShare of their portfolioValueSharesLast quarterShares movedQuarter
1Peter KolchinskyRA Capital Management1.80%$207.6M7.69MNo change0Q2 2026

Sold out last quarter

Quarter by quarter

Superinvestor ownership of MLYS by quarter
QuarterFilings inHoldersCombined sharesCombined valueBoughtSold
Q3 2026920——00
Q2 202615717.69M$207.6M01
Q1 202615717.69M$208.4M12
Q4 202515728.15M$295.7M01
Q3 202515729M$341.2M20
Q2 202515716.15M$83.2M00
Q1 202515616.15M$97.6M10
Q4 202415614.85M$59.7M00

A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.

Each holder's shares

Shares of MLYS held by each superinvestor, by quarter
InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Peter Kolchinsky·7.69M7.69M7.32M7.32M6.15M6.15M4.85M
Andrew Spokes———823.3K1.67M———

A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.

Questions and answers

Which superinvestors own MLYS?

In their latest 13F filings: Peter Kolchinsky (1.80% of the portfolio, $207.6M).

Who sold MLYS last quarter?

Sold out entirely: Steve Cohen (was $51.8M).

How current is this?

It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.

Learn

Cite this page

Funkfolio, “Who owns Mineralys Therapeutics Inc (MLYS)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/MLYS/superinvestors

Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.

Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to MLYS by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.